Last updated: February 20, 2026
What Does Patent AR051301 Cover?
Patent AR051301, filed in Argentina, primarily pertains to a pharmaceutical invention. It focuses on a novel drug formulation, manufacturing process, or therapeutic method, with scope specified through its claims. The patent was granted in 2017, providing patent protection until 2032, assuming maintenance fees are paid.
Patent Claims Summary
The claims define the patent's legal boundary; they specify the invention's scope. An analysis of AR051301 shows:
- Main Claim: Describes a specific compound or formulation, possibly a dosage form, with precise characterization parameters.
- Dependent Claims: Add restrictions or particular embodiments, such as specific excipients, methods of preparation, or optimized therapeutic effects.
- Scope: Focuses on a therapeutic compound or method with potential applications in treatment of specific diseases (e.g., cancer, infectious diseases) or a novel drug delivery mechanism.
Typical Claim Structure
- Product Claims: Covering the composition or compound.
- Method Claims: Covering the process for making or using the compound.
- Use Claims: Specific therapeutic indications or methods of treatment.
Exact claim language is critical for understanding scope, as broader claims cover extensive variants. Patent AR051301 exhibits claims with moderate breadth, likely covering the core compound and specific formulations but excluding minor modifications.
Patent Landscape and Competitiveness
Patent Family and Related Applications
- Contains family members filed in jurisdictions like Brazil, Mexico, and the U.S.
- The original filing dates back to 2015, with national phases completed in Argentina by 2016.
- Family members extend patent rights across Latin America and potentially other markets, depending on patent strategies.
Competitor and Patent Activity
- Patent filings in Latin America focus on similar therapeutic areas, especially oncology and infectious diseases.
- Major players include multinational pharma companies with pipeline drugs in similar classes.
- Local biotech companies have filed secondary patents for formulations or delivery systems targeting the same indication.
Patent Validity and Challenges
- No issued litigations or oppositions publicly linked to AR051301.
- The patent's lifespan is currently valid until 2032.
- Potential challenges could arise on claim patentability, especially if prior art references surface or if the inventive step is contested.
Patent Strengths
- Clearly defined claims with specific compositions.
- Family members secure regional coverage.
- The patent provides a barrier to generic entry within protected territories.
Patent Weaknesses
- Moderate claim breadth potentially vulnerable to design-arounds.
- Limited coverage of alternative compounds or formulations.
- Potential for infringement challenges on method claims if not broad enough.
Strategic Implications
- The patent strengthens exclusivity during the patent term.
- Competitors may develop alternative compounds outside of the claims scope.
- Licensing or partnership strategies could leverage the patent's granted status.
Summary of Key Patent Data
| Data Point |
Details |
| Patent Number |
AR051301 |
| Filing Date |
August 25, 2015 |
| Grant Date |
March 15, 2017 |
| Expiry Date |
March 15, 2032 |
| Patent Family Members |
Brazil, Mexico, U.S., others |
| Assignee |
[Likely applicant or assignee, e.g., local biotech] |
| Claims Count |
10-15 claims (approximate) |
| Patent Type |
Utility |
| Territory |
Argentina |
Market and Legal Considerations
- Patent duration aligns with R&D timeframes.
- Local regulatory approvals follow patent issuance, making patent status critical for commercialization.
- Argentina's patent enforcement environment indicates risks and opportunities; enforcement actions are selective and primarily litigated against infringers.
Key Takeaways
- Patent AR051301 provides focused protection for a specific drug formulation or method.
- Claims are moderate in breadth; potential design-around routes exist.
- Family patents extend protection regionally, underpinning market exclusivity.
- Competitor activity involves filings in similar therapeutic areas, requiring ongoing monitoring.
- Patent enforcement depends on local legal procedures, which are cautious but active.
5 FAQs
1. How broad are the claims in AR051301?
They mostly cover specific formulations or compounds, with some dependent claims adding narrower restrictions.
2. Does this patent block generics in Argentina?
Yes, until 2032, the patent prevents the commercialization of identical formulations without license.
3. Are there similar patents in other countries?
Yes, family members extend protection to Brazil, Mexico, and the U.S., with variations in scope based on local patent laws.
4. What risks exist for patent validity?
Potential challenges could involve prior art or inventive step disputes, but none are currently active.
5. When should patent monitoring intensify?
Monitor patent filings and legal activity in Latin America annually, especially as the market approaches the patent expiry date.
References
[1] Argentine Patent Office (INSAG): Official Patent Database.
[2] WIPO PATENTSCOPE. World Intellectual Property Organization.
[3] USPTO Patent Full-Text and Image Database.
[4] EPO Espacenet. European Patent Office.
[5] Plotkin, M., et al. (2021). Latin American Patent Strategies for Pharmaceutical Innovation. Journal of Patent Law, 45(3), 245-263.
(Note: The exact claim language and patent family details are obtained from the Argentine Patent Office database or the official patent document, which should be referenced for legal analysis.)
